Low-dose Kuanxiong Aerosol's synergistic components provide broader cardioprotection in acute myocardial infarction rats than high-dose or single agents.
Does Kuanxiong Aerosol provide better cardioprotective effects compared to its individual components in a rat model of acute myocardial infarction?
Low-dose, multi-component Kuanxiong Aerosol provides synergistic cardioprotection in a rat model of acute myocardial infarction compared to single-agent approaches.
KXA's cardioprotection stems from the synergistic action of its components targeting ischemia, fibrosis, inflammation, and cardiac dysfunction. This study provides evidence supporting the cardioprotective potential of low-dose, multi-component KXA, indicating that such balanced formulations may offer broader benefits than high-dose or single-agent approaches. Further research is needed to elucidate the molecular mechanisms and refine the formulation for clinical translation.
Qian et al. (2026) studied this question. Low-dose Kuanxiong Aerosol's synergistic components provide broader cardioprotection in acute myocardial infarction rats than high-dose or single agents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: